Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002300903 | SCV002588163 | uncertain significance | not provided | 2022-04-28 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002443295 | SCV002732780 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2024-12-09 | criteria provided, single submitter | clinical testing | The p.L818P variant (also known as c.2453T>C), located in coding exon 21 of the LZTR1 gene, results from a T to C substitution at nucleotide position 2453. The leucine at codon 818 is replaced by proline, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005025774 | SCV005656777 | uncertain significance | Noonan syndrome 2; LZTR1-related schwannomatosis; Noonan syndrome 10 | 2023-12-29 | criteria provided, single submitter | clinical testing |